Research Article
Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM
Table 1
Active compounds in Xinnaoxin Pill with corresponding pharmacokinetics parameters.
| Number | Molecular name | Structure | OB | DL | HL | HIA | BBB | Herb |
| M01 | Kaempferol | | 42.3 | 0.24 | 14.71 | <70% | Y | R. rosea; L. chinense; H. rhamnoides |
| M02 | Quercetin | | 42.41 | 0.28 | 14.22 | <70% | Y | R. rosea; L. chinense; H. rhamnoides |
| M03 | Rhodiosin_DG | | 37.86 | 0.27 | 14.72 | <70% | N | R. rosea |
| M04 | Rutin_DG | | 47.05 | 0.28 | 14.23 | <70% | Y | R. rosea; H. rhamnoides |
| M05 | (24R)-4alpha-Methyl-24-ethylcholesta-7,25-dien-3beta-yl acetate | | 46.36 | 0.84 | 8.25 | ≥70% | Y | L. chinense |
| M06 | 7-O-Methyl luteolin-6-C-beta-glucoside_DG | | 44.39 | 0.3 | 14.13 | <70% | N | L. chinense |
| M07 | Glycitein | | 50.48 | 0.24 | 16.32 | ≥70% | N | L. chinense |
| M08 | Physcion-8-O-beta-D-gentiobioside_DG | | 80.77 | 0.27 | 30.98 | <70% | N | L. chinense |
| M09 | Mutatoxanthin | | 38.38 | 0.59 | 16.45 | ≥70% | N | L. chinense |
| M10 | Astragalin_DG | | 64.34 | 0.24 | 14.74 | <70% | N | H. rhamnoides |
| M11 | Cholesteryl benzoate | | 48.08 | 0.84 | 8.12 | ≥70% | N | H. rhamnoides |
| M12 | Isorhamnetin-3-O-β-rutinoside_DG | | 50.13 | 0.31 | 14.35 | <70% | N | H. rhamnoides |
| M13 | Kaempferol-3-glucoside_DG | | 41.91 | 0.24 | 14.75 | <70% | N | H. rhamnoides |
| M14 | Phosphatide | | 31.81 | 0.28 | 30.93 | <70% | N | H. rhamnoides |
| M15 | Vitamin K | | 47.6 | 0.65 | 28.4 | ≥70% | Y | H. rhamnoides |
| M16 | Vitamin P_DG | | 48.07 | 0.27 | 15.62 | <70% | Y | H. rhamnoides |
| M17 |
Qercetin-3-O-galactoside_DG | | 44.61 | 0.28 | 14.36 | <70% | N | H. rhamnoides |
| M18 | (−)-Epicatechin | | 35.78 | 0.77 | 16.33 | <70% | Y | H. rhamnoides |
|
|
represents the compounds that have been deglycosylated (DG); Y: Yes it is crossing BBB; N: Not crossing BBB.
|